Company / Debt per Share
Xenon Pharmaceuticals Inc. Debt per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.42
FY2019
5-year range
-
FY2017-FY2019
Trend
-49.7%
vs FY2018
Sector context
#71 of 82
Health Care
What the data says
Xenon Pharmaceuticals Inc.'s debt per share of $0.42 is lower than 87% of companies in the Health Care sector (FY2019). Increased from $0.34 to $0.42 over the past 2 years.
Based on SEC 10-K filings.
0.42 in FY2019.
Increased from $0.34 to $0.42 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 82This company $0.42 Sector average $151.59
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2019, debt per share decreased 49.7% year-over-year.
- Ranks #71 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.42 | -49.7% |
| FY2018 | $0.83 | +145.0% |
| FY2017 | $0.34 | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026